Talphera, Inc. (TLPH) stock
TLPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.80−0.00 (-0.10%)
Close on Nov 18, 2026Market cap $41.52MP/E –Yield –
Talphera operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Talphera's operating income for the twelve months ending Jun 30, 2026 was -$14.75M. For fiscal 2025 it was -$13.48M. The highest annual figure on record is -$6.67M in fiscal 2013.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$13.48M | – |
| FY2024 | Dec 31, 2024 | -$15.25M | – |
| FY2023 | Dec 31, 2023 | -$16.89M | – |
| FY2022 | Dec 31, 2022 | -$25.30M | – |
| FY2021 | Dec 31, 2021 | -$35.97M | – |
| FY2020 | Dec 31, 2020 | -$40.96M | – |
| FY2019 | Dec 31, 2019 | -$54.21M | – |
| FY2018 | Dec 31, 2018 | -$35.73M | – |
| FY2017 | Dec 31, 2017 | -$38.68M | – |
| FY2016 | Dec 31, 2016 | -$31.96M | – |
| FY2015 | Dec 31, 2015 | -$19.95M | – |
| FY2014 | Dec 31, 2014 | -$37.65M | – |
| FY2013 | Dec 31, 2013 | -$6.67M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.92M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.95M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.45M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.42M | – |
| Q2 FY2025 | Jun 30, 2025 | -$3.69M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.92M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.00M | -176.8% |
| Q3 FY2024 | Sep 30, 2024 | -$3.75M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.27M | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.33M | – |
| Q4 FY2022 | Dec 31, 2022 | $3.90M | – |
| Q3 FY2022 | Sep 30, 2022 | -$6.63M | – |
| Q2 FY2022 | Jun 30, 2022 | -$13.57M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.94M | – |
| Q4 FY2021 | Dec 31, 2021 | -$8.18M | – |
| Q3 FY2021 | Sep 30, 2021 | -$8.63M | – |
| Q2 FY2021 | Jun 30, 2021 | -$10.02M | – |
| Q1 FY2021 | Mar 31, 2021 | -$9.14M | – |
| Q4 FY2020 | Dec 31, 2020 | -$9.24M | – |
| Q3 FY2020 | Sep 30, 2020 | -$9.04M | – |
| Q2 FY2020 | Jun 30, 2020 | -$6.83M | – |
| Q1 FY2020 | Mar 31, 2020 | -$15.85M | – |
| Q4 FY2019 | Dec 31, 2019 | -$14.99M | – |
| Q3 FY2019 | Sep 30, 2019 | -$13.53M | – |
| Q2 FY2019 | Jun 30, 2019 | -$13.36M | – |
| Q1 FY2019 | Mar 31, 2019 | -$12.32M | – |
| Q4 FY2018 | Dec 31, 2018 | -$10.98M | – |
| Q3 FY2018 | Sep 30, 2018 | -$9.33M | – |
| Q2 FY2018 | Jun 30, 2018 | -$7.15M | – |
| Q1 FY2018 | Mar 31, 2018 | -$8.27M | – |
| Q4 FY2017 | Dec 31, 2017 | -$7.81M | – |
| Q3 FY2017 | Sep 30, 2017 | -$8.86M | – |
| Q2 FY2017 | Jun 30, 2017 | -$9.94M | – |
| Q1 FY2017 | Mar 31, 2017 | -$12.07M | – |
| Q4 FY2016 | Dec 31, 2016 | -$7.14M | – |
| Q3 FY2016 | Sep 30, 2016 | -$7.98M | – |
See a number that looks wrong?